The role of hyperglycemia in FAT/CD36 expression and function

Pediatric Surgery International

Volumn 22, Issue 8, 2006, Pages 647-654

  Chen, Min ^a   Yang, Ying Kui ^a   Loux, Tara J ^a   Georgeson, Keith E ^a   Harmon, Carroll M ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; GLUCOSE; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; STREPTOZOCIN; VANADIC ACID;

ADIPOSE TISSUE; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BODY WEIGHT; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; BLOOD GLUCOSE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; INSULIN; INTESTINE, SMALL; MALE; PPAR GAMMA; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN; VANADATES;

EID: 33748588135     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-006-1704-x     Document Type: Article

References (31)

1. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N (1997) Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids 57:17-21
2. Luiken JJ, Glatz JF, Bonen A (2000) Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle. Can J Appl Physiol 25:333-352
3. Coort SL, Luiken JJ, van der Vusse GJ, Bonen A, Glatz JF (2004) Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 32:83-85
4. Ge Y, Elghetany MT (2005) CD36: a multiligand molecule. Lab Hematol 11:31-37
5. Pravenec M, Zidek V, Simakova M et al (1999) Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest 103:1651-1657
6. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275:32523-32529
7. Febbraio M, Guy E, Coburn C et al (2002) The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol Cell Biochem 239:193-197
8. Petrie JR, Collison M, Connell JM, Gould GW, Dominiczak AF (2001) CD36 deficiency and insulin resistance. Lancet 358:242-243; author reply 244
9. Nozaki S, Tanaka T, Yamashita S et al (1999) CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 192:129-135
10. Furuhashi M, Ura N, Nakata T, Tanaka T, Shimamoto K (2004) Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med 21:952-953
11. Heron-Milhavet L, Haluzik M, Yakar S et al (2004) Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology 145:4667-4676
12. Kaloyianni M, Zolota Z, Paletas K, Tsapas A, Koliakos G (2005) Cariporide counteracts atherosclerosis-related functions in monocytes from obese and normal individuals. Obes Res 13:1588-1595
13. Hayek T, Hussein K, Aviram M et al (2005) Macrophage-foam cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose. Atherosclerosis 183:25-33
14. Courtneidge SA, Smith AE (1983) Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439
15. Luiken JJ, Arumugam Y, Bell RC et al (2002) Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 283:E612-E621
16. Drover VA, Abumrad NA (2005) CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors. Biochem Soc Trans 33:311-315
17. Chiasson JL, Brindisi MC, Rabasa-Lhoret R (2005) The prevention of type 2 diabetes: what is the evidence? Minerva Endocrinol 30:179-191
18. Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T (2005) Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care 28:1876-1881
19. Tkac I (2005) Metabolic syndrome in relationship to type (2) diabetes and atherosclerosis. Diabetes Res Clin Pract 68(Suppl 1):S2-S9
20. Van Nieuwenhoven FA, Luiken JJ, De Jong YF, Grimaldi PA, Van der Vusse GJ, Glatz JF (1998) Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2). J Lipid Res 39:2039-2047
21. Bonnefont-Rousselot D (2002) Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5:561-568
22. Wendt T, Bucciarelli L, Qu W et al (2002) Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4:228-237
23. Forbes JM, Yee LT, Thallas V et al (2004) Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53:1813-1823
24. Maziere C, Auclair M, Rose-Robert F, Leflon P, Maziere JC (1995) Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett 363:277-279
25. Ibrahimi A, Abumrad NA (2002) Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 5:139-145
26. Horiuchi S, Unno Y, Usui H et al (2005) Pathological roles of advanced glycation end product receptors SR-A and CD36. Ann N Y Acad Sci 1043:671-675
27. Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S (2005) Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia 48:1401-1410
28. Drover VA, Ajmal M, Nassir F et al (2005) CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 115:1290-1297
29. Coort SL, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ (2005) Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J Lipid Res 46:1295-302
30. Bonen A, Campbell SE, Benton CR et al (2004) Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 63:245-249
31. Memon RA, Tecott LH, Nonogaki K et al (2000) Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021-4031